Nivolumab in patients with relapsed or refractory hematologic malignancy: Preliminary results of a phase ib study

Alexander M. Lesokhin, Stephen M. Ansell, Philippe Armand, Emma C. Scott, Ahmad Halwani, Martin Gutierrez, Michael M. Millenson, Adam D. Cohen, Stephen J. Schuster, Daniel Lebovic, Madhav Dhodapkar, David Avigan, Bjoern Chapuy, Azra H. Ligon, Gordon J. Freeman, Scott J. Rodig, Deepika Cattry, Lili Zhu, Joseph F. Grosso, M. Brigid Bradley GarelikMargaret A. Shipp, Ivan Borrello, John Timmerman

Research output: Contribution to journalArticlepeer-review

660 Scopus citations

Fingerprint

Dive into the research topics of 'Nivolumab in patients with relapsed or refractory hematologic malignancy: Preliminary results of a phase ib study'. Together they form a unique fingerprint.

Medicine & Life Sciences